TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication.

Authors: Gonzalez-Orozco, Maria, Tseng, Hsiang-chi, Hage, Adam, Xia, Hongjie, Behera, Padmanava, Afreen, Kazi, Peñaflor-Tellez, Yoatzin, Giraldo, Maria I., Huante, Matthew, Puebla-Clark, Lucinda, van Tol, Sarah, Odle, Abby, Crown, Matthew, Teruel, Natalia, Shelite, Thomas R., Moreno-Contreras, Joaquin, Terasaki, Kaori, Makino, Shinji, Menachery, Vineet, Endsley, Mark

Source: Nature Communications; 11/30/2024, Vol. 15 Issue 1, p1-16, 16p

Subject Terms: COVID-19, VIRAL envelopes, VIRAL replication, CELL death, RECOMBINANT viruses

A strand-specific real-time quantitative RT-PCR assay for distinguishing the genomic and antigenomic RNAs of Rift Valley fever phlebovirus

Authors: Tercero, Breanna, Terasaki, Kaori, Nakagawa, Keisuke, Narayanan, Krishna, Makino, Shinji

Source: In Journal of Virological Methods October 2019 272

Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates

Authors: Terasaki, Kaori, Tercero, Breanna R., Makino, Shinji

Source: In Virus Research 2 May 2016 216:55-65

Protein Phosphatase-1 regulates Rift Valley fever virus replication

Authors: Baer, Alan, Shafagati, Nazly, Benedict, Ashwini, Ammosova, Tatiana, Ivanov, Andrey, Hakami, Ramin M., Terasaki, Kaori, Makino, Shinji, Nekhai, Sergei, Kehn-Hall, Kylene

Source: In Antiviral Research March 2016 127:79-89

Rift Valley fever virus 78kDa envelope protein attenuates virus replication in macrophage-derived cell lines and viral virulence in mice.

Authors: Terasaki, Kaori^1,2 (AUTHOR) katerasa@utmb.edu, Kalveram, Birte³ (AUTHOR), Johnson, Kendra N.¹ (AUTHOR), Juelich, Terry³ (AUTHOR), Smith, Jennifer K.³ (AUTHOR), Zhang, Lihong³ (AUTHOR), Freiberg, Alexander N.^2,3,4,5,6 (AUTHOR), Makino, Shinji^1,2,4,5,6 (AUTHOR) katerasa@utmb.edu

Source: PLoS Neglected Tropical Diseases. 9/13/2021, Vol. 15 Issue 9, p1-20. 20p.

Subject Terms: *RIFT Valley fever, *VIRAL envelopes, *VIRAL replication, *CELL lines, *RABIES virus, *VIRAL proteins, *VIRUS virulence

Company/Entity: UNITED States. Food & Drug Administration

Generation of a Single-Cycle Replicable Rift Valley Fever Vaccine

Authors: Murakami, Shin, Terasaki, Kaori, Makino, Shinji

Source: Methods in molecular biology. 1403:187-206

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN606855241&indx=1&recIds=ETOCRN606855241

Identification of a 1.4-kb-Long Sequence Located in the nsp12 and nsp13 Coding Regions of SARS-CoV-2 Genomic RNA That Mediates Efficient Viral RNA Packaging.

Authors: Terasaki, Kaori^1,2 katerasa@utmb.edu, Narayanan, Krishna¹, Makino, Shinji^1,2,3,4,5 shmakino@utmb.edu

Source: Journal of Virology. Jul2023, Vol. 97 Issue 7, p1-13. 13p.

Subject Terms: *SARS-CoV-2, *VIRAL genomes, *HEPATITIS A virus, *RNA, *RNA synthesis, *RNA viruses

Mechanism of tripartite RNA genome packaging in Rift Valley fever virus

Authors: Terasaki, Kaori, Murakami, Shin, Lokugamage, Kumari G., Makino, Shinji, Palese, Peter

Source: Proceedings of the National Academy of Sciences of the United States of America, 2011 Jan 01. 108(2), 804-809.

Access URL: https://www.jstor.org/stable/25770862

Mechanistic insight into the efficient packaging of antigenomic S RNA into Rift Valley fever virus particles.

Authors: Tercero, Breanna, Terasaki, Kaori, Narayanan, Krishna, Makino, Shinji

Source: Frontiers in Cellular & Infection Microbiology; 2/16/2023, Vol. 13, p1-12, 12p

Subject Terms: RIFT Valley fever, NON-coding RNA, RNA, NUCLEOTIDE sequencing, GENE expression

A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice.

Authors: Terasaki, Kaori^1,2 (AUTHOR), Juelich, Terry L.³ (AUTHOR), Smith, Jennifer K.³ (AUTHOR), Kalveram, Birte³ (AUTHOR), Perez, David D.³ (AUTHOR), Freiberg, Alexander N.^2,3,4,5,6 (AUTHOR), Makino, Shinji^1,2,4,5,6 (AUTHOR) shmakino@utmb.edu

Source: Scientific Reports. 11/20/2018, Vol. 8 Issue 1, p1-12. 12p.

Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence.

Authors: Terasaki, Kaori¹, Ramirez, Sydney I.², Makino, Shinji^1,3,4,5,6 shmakino@utmb.edu

Source: PLoS Neglected Tropical Diseases. 10/6/2016, Vol. 10 Issue 10, p1-22. 22p.

Subject Terms: *RIFT Valley fever, *MICROBIAL virulence, *TRANSCRIPTION factors, *PROTEIN kinases, *AMINO acids

Interplay between the Virus and Host in Rift Valley Fever Pathogenesis.

Authors: Terasaki, Kaori¹ katerasa@utmb.edu, Makino, Shinji¹

Source: Journal of Innate Immunity. Aug2015, Vol. 7 Issue 5, p450-458. 9p.

Development of a Novel, Single-Cycle Replicable Rift Valley Fever Vaccine.

Authors: Murakami, Shin¹ (AUTHOR), Terasaki, Kaori¹ (AUTHOR), Ramirez, Sydney I.² (AUTHOR), Morrill, John C.¹ (AUTHOR), Makino, Shinji^1,3,4,5 (AUTHOR) shmakino@utmb.edu

Source: PLoS Neglected Tropical Diseases. 3/20/2014, Vol. 8 Issue 3, p1-13. 13p.

Subject Terms: *RIFT Valley fever, *NEUTRALIZATION tests, *GREEN fluorescent protein, *VIRAL envelope proteins, *AMPLIFICATION reactions, *VIRUS-like particles, *IMMUNIZATION of children, *ALPHAVIRUSES, *VIRAL encephalitis

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.